Company profile: Tremitas
1.1 - Company Overview
Company description
- Provider of Tremipen, a medical measuring device for Parkinson's disease and other tremor conditions, enabling patients to safely and reliably self-measure and quantify tremor strength and frequency with simple, thermometer-like usability.
Products and services
- Tremipen: A medical-grade device enabling tremor patients to self-measure tremor strength and frequency safely and reliably, easy to use as a clinical thermometer for Parkinson and other tremor diseases.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tremitas
Osteal Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage specialty pharmaceutical treatments for orthopedic infections, including VT-X7, a drug-device combination delivering high concentrations of vancomycin and tobramycin to the infected joint space for use in two-stage exchange arthroplasty to treat periprosthetic joint infections, and the APEX-2 clinical trial evaluating a 7-day VT-X7 treatment for hip or knee periprosthetic joint infection versus standard two-stage exchange surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Osteal Therapeutics company profile →
Voom Medical Devices
HQ: United States
Website
- Description: Provider of orthopedic medical devices and appliances for minimally invasive bunion surgery, offering the Bunionplasty® 360 Bunion Repair™ procedure, Revcon™ single-screw fixation system, Transveron™ osteotomy technique, and NervPreserv™ method, plus one-on-one and comprehensive surgeon training with didactic and hands-on cadaver labs and ongoing support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Voom Medical Devices company profile →
OST Laboratoires
HQ: France
Website
- Description: Provider of solutions for orthopaedic and dental applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OST Laboratoires company profile →
Novosteo
HQ: United States
Website
- Description: Provider of therapeutics for bone injuries and diseases, developing and delivering new drugs to reduce complications from bone fractures (including fall-related) and to address bone metastasis and infection, aiming to lower morbidity, mortality, and loss of mobility and productivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Novosteo company profile →
Fior & Gentz
HQ: Germany
Website
- Description: Provider of lower limb neuroorthotic components, developing and manufacturing functional ankle and knee joints used in custom-made neuroorthotic devices for people with neurological conditions causing gait impairments, such as stroke, multiple sclerosis, and spinal cord injuries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fior & Gentz company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tremitas
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tremitas
2.2 - Growth funds investing in similar companies to Tremitas
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tremitas
4.2 - Public trading comparable groups for Tremitas
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →